Industry Strength Score
39/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
NANOREPRO AG (NN6.DE) Stock Price & Overview
FRA:NN6 • DE0006577109
Current stock price
1.515 EUR
-0.02 (-0.98%)
Last:
The current stock price of NN6.DE is 1.515 EUR. Today NN6.DE is down by -0.98%. In the past month the price increased by 9.39%. In the past year, price increased by 6.69%.
NN6.DE Key Statistics
52-Week Range1.165 - 2.12
Current NN6.DE stock price positioned within its 52-week range.
1-Month Range1.365 - 1.6
Current NN6.DE stock price positioned within its 1-month range.
- Market Cap
- 19.544M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.13
- Dividend Yield
- 6.98%
NN6.DE Stock Performance
Today
-0.98%
1 Week
-2.88%
1 Month
+9.39%
3 Months
-0.98%
Longer-term
6 Months -10.36%
1 Year +6.69%
2 Years -17.21%
3 Years -31.45%
5 Years -84.76%
10 Years +45.81%
NN6.DE Stock Chart
NN6.DE Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to NN6.DE. When comparing the yearly performance of all stocks, NN6.DE turns out to be only a medium performer in the overall market: it outperformed 44.33% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
NN6.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to NN6.DE. No worries on liquidiy or solvency for NN6.DE as it has an excellent financial health rating, but there are worries on the profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
NN6.DE Earnings
Next Earnings DateN/A
Last Earnings DateN/A
PeriodQ2 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
NN6.DE Forecast & Estimates
5 analysts have analysed NN6.DE and the average price target is 4.59 EUR. This implies a price increase of 202.97% is expected in the next year compared to the current price of 1.515.
For the next year, analysts expect an EPS growth of -1.96% and a revenue growth 232.78% for NN6.DE
Analysts
Analysts84
Price Target4.59 (202.97%)
EPS Next Y-1.96%
Revenue Next Year232.78%
NN6.DE Financial Highlights
Over the last trailing twelve months NN6.DE reported a non-GAAP Earnings per Share(EPS) of -0.13. The EPS increased by 41.99% compared to the year before.
Income Statements
Revenue(TTM)5.13M
Net Income(TTM)-1.72M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.54% | ||
| ROE | -4.62% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%27.57%
Sales Q2Q%36.99%
EPS 1Y (TTM)41.99%
Revenue 1Y (TTM)43.94%
NN6.DE Ownership
Ownership
Inst Owners9.02%
Shares12.90M
Float12.36M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
NN6.DE Industry Overview
NN6.DE operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 35 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
70/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
34%
Outperformed 34% of sub-industries
3 Month Rank
30%
Outperformed 30% of sub-industries
6 Month Rank
32%
Outperformed 32% of sub-industries
Industry Fundamentals & Breadth
- Members
- 35
- New Highs
- 2.9%
- New Lows
- 11.4%
- Average ROE
- 9.8%
- Average Profit Margin
- 9.8%
- Average Operating Margin
- 14.8%
- Average P/E
- 15.6
- Average Fwd P/E
- 13.7
- Average Debt/Equity
- 0.6
NN6.DE Competitors/Peers
The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 13.05 | 87.766B | ||
| SHL | SIEMENS HEALTHINEERS AG | 13.17 | 39.345B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 14.77 | 21.56B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 14.76 | 21.55B | ||
| BIM | BIOMERIEUX | 14.88 | 8.486B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 19.4 | 3.731B | ||
| DIA | DIASORIN SPA | 14.33 | 3.246B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 14.14 | 2.368B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.01 | 1.679B | ||
| DRW8 | DRAEGERWERK AG | 8.61 | 1.313B | ||
| ELN | EL.EN. SPA | 17.32 | 1.052B | ||
| EUZ | ECKERT & ZIEGLER SE | 18.95 | 969.315M | ||
| GVS | GVS SPA | 16.11 | 800.231M |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find more growth stocks the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About NN6.DE
Company Profile
NanoRepro AG engages in the development, manufacture, and distribution of diagnostic tests and food supplements for home and professional use. The company is headquartered in Marburg An Der Lahn, Hessen and currently employs 20 full-time employees. The company went IPO on 2012-10-09. The firm is engaged in the research of stem cells, which are used in the medical treatment due to their ability to self-renew and differentiate to a range of specialized cell types. Nanorepro AG gathers samples of patients’ stem cells and stores them for the future use. Its portfolio also comprises OTC rapid diagnostic tests, such as OvuQUICK, an ovulation test for women; GraviQUICK, a pregnancy test; MenoQUICK, a menopause test; VagiQUICK, a vaginal yeast test; GlutenCHECK, a test to detect celiac disease; CholesterinCHECK, a test to measure the level of total cholesterol, HDL and LDL, as well as FertiQUICK, a fertility test for men.
Company Info
IPO: 2012-10-09
NANOREPRO AG
Untergasse 8
Marburg an der Lahn HESSEN DE
Employees: 21
Phone: 496421951449
NANOREPRO AG / NN6.DE FAQ
What does NANOREPRO AG do?
NanoRepro AG engages in the development, manufacture, and distribution of diagnostic tests and food supplements for home and professional use. The company is headquartered in Marburg An Der Lahn, Hessen and currently employs 20 full-time employees. The company went IPO on 2012-10-09. The firm is engaged in the research of stem cells, which are used in the medical treatment due to their ability to self-renew and differentiate to a range of specialized cell types. Nanorepro AG gathers samples of patients’ stem cells and stores them for the future use. Its portfolio also comprises OTC rapid diagnostic tests, such as OvuQUICK, an ovulation test for women; GraviQUICK, a pregnancy test; MenoQUICK, a menopause test; VagiQUICK, a vaginal yeast test; GlutenCHECK, a test to detect celiac disease; CholesterinCHECK, a test to measure the level of total cholesterol, HDL and LDL, as well as FertiQUICK, a fertility test for men.
What is the stock price of NANOREPRO AG today?
The current stock price of NN6.DE is 1.515 EUR. The price decreased by -0.98% in the last trading session.
Does NANOREPRO AG pay dividends?
NANOREPRO AG (NN6.DE) has a dividend yield of 6.98%. The yearly dividend amount is currently 0.
What is the ChartMill rating of NANOREPRO AG stock?
NN6.DE has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the growth outlook for NANOREPRO AG?
The Revenue of NANOREPRO AG (NN6.DE) is expected to grow by 232.78% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the number of employees for NANOREPRO AG?
NANOREPRO AG (NN6.DE) currently has 21 employees.
What is the market capitalization of NN6 stock?
NANOREPRO AG (NN6.DE) has a market capitalization of 19.54M EUR. This makes NN6.DE a Nano Cap stock.